CRBU
Price
$1.70
Change
-$0.02 (-1.16%)
Updated
Dec 26 closing price
Capitalization
158.9M
79 days until earnings call
Intraday BUY SELL Signals
CRSP
Price
$55.08
Change
-$1.63 (-2.87%)
Updated
Dec 26 closing price
Capitalization
5.25B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs CRSP

Header iconCRBU vs CRSP Comparison
Open Charts CRBU vs CRSPBanner chart's image
Caribou Biosciences
Price$1.70
Change-$0.02 (-1.16%)
Volume$780.17K
Capitalization158.9M
CRISPR Therapeutics AG
Price$55.08
Change-$1.63 (-2.87%)
Volume$1.41M
Capitalization5.25B
CRBU vs CRSP Comparison Chart in %
View a ticker or compare two or three
VS
CRBU vs. CRSP commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and CRSP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (CRBU: $1.70 vs. CRSP: $55.08)
Brand notoriety: CRBU and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 29% vs. CRSP: 66%
Market capitalization -- CRBU: $158.9M vs. CRSP: $5.25B
CRBU [@Biotechnology] is valued at $158.9M. CRSP’s [@Biotechnology] market capitalization is $5.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 3 bearish.
  • CRSP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than CRSP.

Price Growth

CRBU (@Biotechnology) experienced а +1.19% price change this week, while CRSP (@Biotechnology) price change was -1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

CRSP is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.25B) has a higher market cap than CRBU($159M). CRSP YTD gains are higher at: 39.939 vs. CRBU (6.918). CRBU has higher annual earnings (EBITDA): -142.47M vs. CRSP (-555.73M). CRSP has more cash in the bank: 1.92B vs. CRBU (147M). CRBU has less debt than CRSP: CRBU (25.5M) vs CRSP (211M). CRSP has higher revenues than CRBU: CRSP (35M) vs CRBU (9.3M).
CRBUCRSPCRBU / CRSP
Capitalization159M5.25B3%
EBITDA-142.47M-555.73M26%
Gain YTD6.91839.93917%
P/E RatioN/AN/A-
Revenue9.3M35M27%
Total Cash147M1.92B8%
Total Debt25.5M211M12%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
CRSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDEFX21.610.04
+0.19%
BlackRock International Select Eq Inv A
CAFEX43.290.04
+0.09%
American Funds AMCAP 529E
ISCAX51.68N/A
N/A
Federated Hermes Intl Small-Mid Co A
GSEUX68.84N/A
N/A
Goldman Sachs US Equity Insights R6
FTXCX51.53-0.13
-0.25%
FullerThaler Behavioral Sm-Cp Gr C

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.16%
CRSP - CRBU
58%
Loosely correlated
-2.87%
BEAM - CRBU
53%
Loosely correlated
-0.57%
RXRX - CRBU
52%
Loosely correlated
-3.41%
SYRE - CRBU
51%
Loosely correlated
-0.33%
AXON - CRBU
50%
Loosely correlated
-1.24%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.87%
BEAM - CRSP
71%
Closely correlated
-0.57%
RXRX - CRSP
67%
Closely correlated
-3.41%
ABSI - CRSP
60%
Loosely correlated
+0.28%
NTLA - CRSP
60%
Loosely correlated
-1.56%
PRME - CRSP
60%
Loosely correlated
-1.96%
More